Apoptosis
The number of cells in multicellular organism is tightly regulated. Not simply by controlling the rate of cell division, but also by controlling the rate of cell death. If cells are no longer needed, they commit suicide by activating an intracellular death program. This process is therefore called programmed cell death or apoptosis (from a Greek word meaning “falling off,” as leaves from a tree). The intrinsic apoptotic pathway occurs by the release of cytochrome c from mitochondria. The extrinsic apoptotic pathway is caused by the binding of death ligands, such as TNF (tumor necrosis factor), Fas, and TRAIL (TNF-related-apoptosis-inducing ligand), to their corresponding receptors. Although programmed cell death is involved in a number of key biological phenomena, aberrant apoptosis results in diverse human diseases [1].
The amount of apoptosis that occurs in developing and adult animal tissues is surprisingly large. In the developing vertebrate nervous system up to half or more of the nerve cells normally die soon after they are formed. In a healthy adult human, billions of cells die in the bone marrow and intestine every hour. Although this process seems remarkably wasteful -especially as the vast majority are perfectly healthy at the time they kill themselves- programmed cell death plays an important role during embryonic development, as hands and feet, for example, are sculpted by apoptosis: they start out as spadelike structures, and the individual digits separate only as the cells between them die. In other cases, cells die when the structure they form is no longer needed. When a tadpole changes into a frog, the cells in the tail die, and the tail, which is not needed in the frog, disappears. In many other cases, cell death helps regulate cell numbers. In the developing nervous system, for example, cell death adjusts the number of nerve cells to match the number of target cells that require innervation. In all these cases, the cells die by apoptosis as well[2].
[2] D.R. Williams et al. An apoptosis-inducing small molecule that binds to heat shock protein 70. Angew. Chem. Int. Ed. Engl. 2008, 47, 7466-7469.
[1] B. Alberts, A. Johnson, J. Lewis et al. Molecular Biology of the Cell. 4th edition. New York. Garland Science, 2002.
Axon ID | Name | Description | From price | |
---|---|---|---|---|
3735 | ZZW-115 trihydrochloride | Potent NUPR1 inhibitor | €140.00 | |
2445 | ZLN 024 | Allosteric activator of AMP-activated protein kinase (AMPK) | €90.00 | |
4142 | Z29077885 hydrochloride | Potent STK33 inhibitor; Antiviral agent | Recently added | €120.00 |
4239 | Z29077885 | Potent STK33 inhibitor; Antiviral agent | Recently added | €120.00 |
2159 | Z-VAD-FMK | Pan-caspase inhibitor with in vivo activity | Inquire | |
2675 | YMU1 | Selective inhibitor of human thymidylate kinase (hTMPK) | €110.00 | |
2607 | YM201636 | Selective inhibitor of PIKfyve (type III PtdInsP kinase) | €65.00 | |
1639 | YM155 | Survivin suppressant | €95.00 | |
2469 | YK 4-279 | Inhibitor of ETV1, ERG and interactions of EWS-FLI1 and RNA helicase A | €95.00 | |
3789 | YH-306 | FAK inhibitor | €90.00 | |
2951 | XL 388 | Highly potent, selective, ATP-competitive, and orally bioavailable mTOR inhibitor | €125.00 | |
4119 | XIE62-1004 | Autophagy inducer; p62-LC3 interaction facilitator | Recently added | €110.00 |
1985 | Xevinapant | Antagonist of Inhibitor of apoptosis proteins (IAPs) | €145.00 | |
2337 | XCT 790 | ERRα inverse agonist and potent mitochondrial uncoupler | €120.00 | |
2385 | WZ 4003 | Specific dual inhibitor of NUAK1 (ARK5) and NUAK2 (SNARK) | €80.00 | |
3995 | WT-161 | Potent,selective,and bioavailable HDAC6 inhibitor | Inquire | |
1779 | WP 1130 | Deubiquitinase Inhibitor | €95.00 | |
2316 | WP 1066 | Potent JAK2 and STAT3 inhibitor and downregulator of antiapoptotic proteins | €95.00 | |
2120 | Wnt agonist 1 | Wnt/β-catenin signaling pathway agonist or activator | €90.00 | |
3068 | WEHI-9625 | First-in-class, potent, and selective mBAK-mediated apoptosis inhibitor | €150.00 | |
2325 | WAY 316606 hydrochloride | Potent inhibitor of sFRP-1 that stimulates Wnt signaling | €85.00 | |
3801 | Voruciclib | Inhibitor of CDK9 | Inquire | |
3114 | Vorinostat | HDAC inhibitor | €45.00 | |
3354 | Verteporfin | Inhibitor of TEAD-YAP association; Photosensitizer | €90.00 | |
1608 | VER 155008 | Hsp70 inhibitor | €95.00 | |
2452 | VE 822 | Selective ATR inhibitor that decreases survival of pancreatic cancer cells | €110.00 | |
1893 | VE 821 | Inhibitor of the DNA damage response kinase ATR | €80.00 | |
3722 | Valemetostat | Inhibitor of Histone Lysine Methyltransferase EZH1/2 | €160.00 | |
3288 | Vadadustat | Oral HIF-PH inhibitor and HIF stabilizer | €80.00 | |
2991 | USP7-USP47 inhibitor | Selective inhibitor of deubiquitinase USP7 and USP47 | €90.00 |